BioMarin Pharmaceutical, Inc. (BMRN)

54.59 -0.48 (-0.87%) USD  |  NASDAQ  |  Jan 16, 16:00
54.66 +0.07 (+0.13%) After-Hours: 06:05
More

BioMarin Pharmaceutical Normalized Income (Quarterly)

Normalized Income (Quarterly) Chart

View Normalized Income (Quarterly) for BMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Normalized Income (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Normalized Income (Quarterly) Range, Past 5 Years

View Normalized Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Normalized Income (Quarterly) Benchmarks

View Normalized Income (Quarterly) Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Merck & Co., Inc. Upgrade
AbbVie, Inc. Upgrade
Biogen, Inc. Upgrade